Glenmark Pharmaceuticals Limited Analysis
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
14.70
|
12.55
|
-2.15
|
-14.63%
|
|
2024-06-30
|
11.30
|
12.06
|
0.76
|
6.73%
|
|
2024-03-31
|
5.50
|
-28.20
|
-33.70
|
-612.76%
|
|
2023-09-30
|
0.00
|
4.41
|
0.00
|
0.00%
|
|
2023-06-30
|
10.74
|
7.15
|
-3.59
|
-33.43%
|
|
2023-03-31
|
10.77
|
13.17
|
2.40
|
22.28%
|
|
2022-09-30
|
8.28
|
9.20
|
0.92
|
11.11%
|
|
2022-06-30
|
7.32
|
6.82
|
-0.50
|
-6.83%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
24.61
|
|
2024-03-31
|
-16.64
|
|
2023-03-31
|
29.19
|
|
2022-03-31
|
39.51
|
|
2021-03-31
|
32.96
|
|
2020-03-31
|
26.80
|
|
2019-03-31
|
27.28
|
|
2018-03-31
|
28.49
|
|
2017-03-31
|
42.12
|
|
2016-03-31
|
26.58
|
|
2015-03-31
|
25.88
|
|
2014-03-31
|
22.75
|